Research interests
Dr. Muro's research sits at the interface between cellular biology, nanotechnology, and drug delivery. She studies the biological mechanisms ruling how our tissues transport cargoes within our bodies and applies this knowledge to design of nanodevices for delivery of therapeutics to specific disease sites. Focusing on genetic conditions that cause metabolic, neurodegenerative and cardiovascular syndromes, as well as on a new transport pathway she helped discover, her goal is to gain efficient access within the body and its cells, to enable effective treatment of these life-threatening disorders.
Selected publications
- Placci M, Giannotti MI & Muro S 2023, 'Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders', Advanced Drug Delivery Reviews, 197, 114683.
- Nong J, Glassman PM, Myerson JW, et al. 2023, 'Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain', Acs Nano, 17, 14, 13121 - 13136.
- Loeck M, Placci M & Muro S 2023, 'Effect of acid sphingomyelinase deficiency in type A Niemann-Pick disease on the transport of therapeutic nanocarriers across the blood-brain barrier', Drug Delivery And Translational Research, AHEAD
- del Moral, Maria; Loeck, Maximilian; Muntimadugu, Eameema; Vives, Guillem; Pham, Vy; Pfeifer, Peter; Battaglia, Giuseppe; Muro, Silvia; Andrianov, Alexander K. 2023, 'Role of the Lactide:Glycolide Ratio in PLGA Nanoparticle Stability and Release under Lysosomal Conditions for Enzyme Replacement Therapy of Lysosomal Storage Disorders', Journal Of Functional Biomaterials, 14, 9, 440.